Walleye Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.63M Sell
9,000
-57,000
-86% -$18.7M 0.01% 1250
2025
Q4
$23.1M Buy
66,000
+16,700
+34% +$5.64M 0.07% 245
2025
Q3
$15.9M Buy
49,300
+1,600
+3% +$498K 0.06% 335
2025
Q2
$18.6M Buy
47,700
+17,500
+58% +$7.04M 0.07% 263
2025
Q1
$13.1M Buy
30,200
+3,400
+13% +$1.36M 0.06% 325
2024
Q4
$9.89M Sell
26,800
-9,900
-27% -$4.14M 0.02% 635
2024
Q3
$19.1M Buy
36,700
+6,400
+21% +$3.42M 0.04% 351
2024
Q2
$16.4M Sell
30,300
-31,100
-51% -$16.4M 0.03% 455
2024
Q1
$31.8M Buy
61,400
+18,100
+42% +$9M 0.06% 242
2023
Q4
$20.4M Buy
43,300
+22,300
+106% +$10.3M 0.04% 320
2023
Q3
$9.14M Buy
21,000
+5,400
+35% +$2.45M 0.02% 625
2023
Q2
$6.93M Buy
15,600
+9,900
+174% +$4.57M 0.03% 564
2023
Q1
$2.62M Buy
+5,700
New +$2.71M 0.04% 572
2020
Q1
Sell
-1,400
Closed -$423K 1140
2019
Q4
$423K Sell
1,400
-3,100
-69% -$853K 0.03% 758
2019
Q3
$1.08M Buy
+4,500
New +$1.23M 0.06% 420
2019
Q2
Sell
-1,000
Closed -$287K 1814
2019
Q1
$287K Buy
+1,000
New +$289K 0.05% 620

Other funds holding ELV

Walleye Capital's ELV Position: Q1 2026 in Review

Walleye Capital reduced its Elevance Health (ELV) stake by 97% in Q1 2026, selling an estimated $34.9M and leaving 3,024 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

Walleye Capital first reported a position in ELV in Q3 2018 and has held it in 17 quarters since. The position peaked at $38.3M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Walleye Capital held 3,024 shares of Elevance Health worth $885K as of Q1 2026.
  • Walleye Capital sold 106,159 Elevance Health shares in Q1 2026, an estimated $34.9M.
  • Elevance Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2192 holding.
  • Walleye Capital first reported a position in Elevance Health in Q3 2018 and has held it in 17 quarters since.
  • Walleye Capital's Elevance Health position peaked at $38.3M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.